By my count there will be 2 licenses included in the 10q. Rockwell and Respironics. Based on the value of the licenses of the last 10q, I'd anticipate PDS having received approximately $1.46M in licensing revenue BEFORE expenses. Therefore, PTSC's likely to experience a loss from the PDS venture this quarter, in my opinion.

It will be interesting to see what kind of operating expenses will be associated with the Crossflo acquisition since it wil be a full quarter of operations included in the report.

Overall, I'm expecting a loss this quarter. The magnitude of the loss will depend on the Crossflo expenses, in my opinion. I don't know whether the revenues PTSC gets from its other ventures (Holocom, etc.) will be enough to offset the Crossflo losses and the PDS losses for the quarter.